Shin Nippon Biomedical <2395.T>-6-month group

Nov 12 (Reuters) -

SHIN NIPPON BIOMEDICAL LABORATORIES LTD

CONSOLIDATED EARNINGS ESTIMATES
(in billions of yen unless specified)

6 months to 6 months to

Sept 30,2009 Sept 30,2009

LATEST PREVIOUS

FORECAST FORECAST
Sales 10.33 9.75
Operating 579 mln 300 mln
Recurring 313 mln 130 mln
Net 578 mln 100 mln

NOTE - Shin Nippon Biomedical Laboratories Ltd provides
clinical trial and other support services for drug
development.

For latest earnings estimates made by Toyo Keizai, please
double click on 2395.TK1.